Professional Documents
Culture Documents
Protocol: Oxytocin
Drug: Oxytocin (Pitocin)
Indication for Use: Treatment of Postpartum Hemorrhage
Mechanism of Action: Uterine stimulant, vasopressive, & antidiuretic effects; activates G-protein-coupled receptors
that trigger increases in intracellular calcium levels in uterine myofibrils, which result in uterine contractions; increases
local prostaglandin production, which further stimulates uterine contraction.
Contraindications: Significant cephalopelvic disproportion. Unfavorable fetal positions or presentations, eg, transverse
lies, which are undeliverable without conversion prior to delivery. Obstetric emergencies that favor surgery. Fetal
distress where delivery is not imminent. Where adequate uterine activity fails to achieve satisfactory progress.
Hyperactive or hypertonic uterus. Contraindicated vaginal delivery, eg, invasive cervical carcinoma, active herpes
genitalis, total placenta previa, vasa previa & cord presentation or prolapse of cord. Hypersensitivity. Fetal distress,
polyhydramnios, partial placenta previa, prematurity, borderline cephalopelvic disproportion, previous major surgery of
cervix or uterus (including cesarean), overdistention of uterus, grand mulitparity, invasive cervical carcinoma, history of
uterine sepsis or traumatic delivery. Hyperstimulation of the uterus, with strong (hypertonic) and/or prolonged (tetanic)
contractions, or a resting uterine tone of 15-20 mm H20 between contractions may occur, possibly resulting in uterine
rupture, cervical & vaginal lacerations, postpartum hemorrhage, placenta abruption, impaired uterine blood flow,
amniotic fluid embolism, & fetal trauma including intracranial hemorrhage. Not indicated for elective labor induction.